Dermatología  Peruana
© Círculo Dermatológico del Perú
ISSN versión electrónica 1028-7175

Dermatol. Per.     1998; 8 (1) : 11-17

EFECTOS DEL BROMURO BENZALCONIO SOBRE EL SISTEMA
INMUNE Y SU RELEVANCIA A LA INHIBICIÓN DEL VIRUS DEL SIDA

Patarca, Roberto.*; Fletcher, Mary Ann*

BIBLIOGRAFÍA

  1. ALWainberg, M.A., Spira, B., Bleau, G. and Thomas, R. Inactivation of human immunocleficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. J. Clin. Microbiol., 1990; 28(1):156-64979;158.

  1. Feng, Y., Broder, C.C., Kennedy, P. E., and Berger, E.A. HIV-64979;1 entry cofactor: Functional cDNA cioning of a seven-64979;transmembrane, G protein-64979;coupled receptor. Science, 1996; 272:872-64979;877.

  2. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P.D., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B., Peiper, S.C., Schali, T.J., Littman, D.R., and Landau, N.R. ldentification of a major recpetor for primary isolates of HIV-64979;1. Nature, 1996; 381(6584):661-64979;666.

  3. Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagashima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P., and Paxton, W.A. HIV-64979;1 entry into CID4+ cells is mediated by the chemokine receptor CC-64979;CKR-64979;5. Nature, 1996; 381(6584):667-64979;673.

  4. Gallo, C.J., Hand, A.R., Jones, T.L., and Jaffe, L.A. Stimulation of Xenopus oocyte maturation by inhibition of the G-64979;protein alpha S subunit, a component of the plasma membrane and yolk platelet membranes. J. Cell Biol., 1995; 130(2):275-64979;284.

  5. Kinane, T.B., Finder, J.D., Kawashirna, A., Brown, D., Abbate, M., Fredericks, W.J., Sukhatme, V.P., Rauscher, F.J.III, and Ercolani, L. LL-64979;C-64979;PK1 cell growth is repressed by WT1 inhibition of G-64979;protein alpha i-64979;2 protooncogene transcription. J. Biol. Chem., 1995; 270(51):30760-64979;30764.

  6. Strader, C.D., T.M. Fong, M.R. Tota, D. Underwood, D., and Dixon, R.A.F. Structure and function of G protein-64979;cpupled receptors. Annu. Rev. Biochem., 1994; 63:101-64979;132.

  7. Withrow, T.J., Brown, N.T., Hitchins, V.M., and Strickland, A.G. Cytotoxicity and mutagenicity of ophthalmic solution preservatives and UVA radiation in L-64979;5178Y celis. Photochernistry & Photobiology, 1989; 50(3):385-64979;389.

  8. Damour, 0., Hua, S.Z., Lasne, F., Villain, M., Rousselle, P., and Collombel, C. Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns, 1992; 18(6):479-485.

  9. Cunliffe, IA., Mclntyre, C.A., Rees, R.C., and Rennie, 1.G. The effecl of topical cholinergic medications on human Tenon's capsule fibroblasts in tissue culture. Graefes Archive for Clin. & Exp. Ophthalmol., 1995; 233(8):507-64979;512.

  10. Cunliffe, IA., McIntyre, C.A., Rees, R.C., and Rennie, I.G. Pilot study on the effect of topical adrenergic medications on human Tenon's capsule fibroblasts in tissue culture. Br. J. 0phthaIrnol., 1995; 79(1):70-75.

  11. Kajino, T.: Effect of benzalkonium chloride on cultured V79 cells. Shigaku -64979; Odontology, 1987; 75(1):63-74.

  12. Samples, J.R., Binder, P.S., and Nayak, S. The effect of epinephrine and benzalkonium chloride on cultured corneal endothelial and trabecular meshwork cells. Exp. Eye Res., 1989; 49(1):1-64979;12.

  13. Eun, H.C., Chung, J.H., Jung, S.Y., Cho, K.H., and Kim, K.H. A comparative study of the cytotoxicity of skin irritants on cultured human oral and skin keratinocytes. Br. J. Dermatol., 1994; 130(1):24-64979;28.

  14. Fabreguette, A., Zhi Hua, S., Lasne, F., and Damour, 0. Evaluation of the cytotoxicity of antiseptics used in current practice on cultures of fibroblasts and keratinocytes. Pathologie Biologie, 1994; 42(9):888-892.

  15. Muller-64979;Decker, K., Furstenberger, G., and Marks, F. Keratinocyte-64979;derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test. Toxicol. & Applied Pharmacol., 1994; 127(1):99-64979;108.

  16. Fletcher, M.A., Baron, G.C., Ashman, M.R., Fischi, M.A., and Ornas, N.G. The use of whole blood methocis in assessment of immune parameters in immunodeficiency states. Diagn. Clin. Immunol., 1987;5:69-64979;81.

  17. Fletcher, M.A., Azen, S., Adelberg, B., Gjerset, G., Hassett, J., Kaplan, J., Niland, J., Odom-64979;Maryon, T., Parker, J., Stites, D., Mosely, J., and the Transfusion Safety Study Group. Immunophenotyping in a multicenter study: the transfusion safety experience. Clin. Immunol. Immunopathol., 1989; 52:38-64979;47.

  18. Patarca, R., Sandler, D., Walling, J., Klimas, N.G., and Fletcher, M.A. Assessment of immune mediator expression leveis in biological fluicis and cells: a critical appraisal. Crit. Rev. Oncog., 1995; 6(2):117- 149.

  19. Patarca, R., Fletcher, M.A., and Podack, E.R. Cytolytic cell functions. In: Manual of Clinical Laboratory Immunology. Rose, N.R., de Macario, E.C., Folds, J.D., Lane, H.C., and Nakarnura, R.M. (Eds.) 5th ed. Arnerican Society for Microbiology Washington, D.C. (1996).

  20. Li, M., Yang, J., Shen, G.X., Zhang, Q., Liu, S.P., Liu, Z.B., and Ye, W.X. Study on lymphocyte activation and proliferation induced by anti-64979;CD3 MoAb. J. Tongji Med. Unív., 1994; 14(4):209-64979;212.

  21. Burstein, S., Budrow, J., Debatis, M., Hunter, S.A., and Subrarnanian, A. Phospholipase participation in cannabinoid-64979;índuced release of free arachidonic acid. Biochemical Pharmacol., 1994; 48(6):1253-64979;64.

  22. Ka-minski, N.E., Koh, W.S., Yang, K.H., Lee, M., and Kessler, F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertusis toxin-64979;sensitive G-64979;protein coupled mechanism. Biochemical Pharmacol., 1994; 48(10):1899-64979;1908.

  23. Dubois, P.M., Andris, F., Shapiro, R.A.,Gilliland, L.K., Kaufrnan, M., Urbain, J,, Ledbetter, J.A., and Leo, 0. T cell long-64979;term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction. Eur. J. Immunol., 1994; 24(2):348-64979;354.

  24. Stewart, S.J., Cunningharn, G.R., and House, F.S. Activation of phospholipase D following perturbation of the human T lymphocyte antigen receptor/CD3 complex is dependent upon protein kinase C. Cellular Signalling, 1993; 5(3):315-64979;323.

  25. Ohmura, T., Sakata, A., and Onoue, K. A 68-64979;kD GTP-64979;binding protein associated with the T cell receptor complex. J. Exp. Med., 1992; 176(3):887-64979;891.

  26. Shan, X., Luo, H., Houle, B., and Wu, J. Expression of a G-64979;protein beta subunit-64979;related gene during lymphocyte activation. Int. Immunol., 1994; 6(5):739-64979;749.

  27. Mattson, E., Van Dijk, H., Van Kessel, K., Verhoef, J., Fleer, A., and Rollof, J. Intracellular pathways involved in tumor necrosis factor-64979;alpha release by human monocytes on stimulation with lipopolysac charide or staphylococcal peptidoglycan are partly similar. J. Inf. Dis., 1996; 173(1):212-64979;218.

  28. Merrill, J.E., Koyanagi, Y., and Chen, I.S.Y. Interleukin-64979;1 and tumor necrosis factor a con be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol., 1989; 63:4404-64979;4408.

  29. Vyakarnam, A., McKeating, J., Meager, A., and Beverly, P.C. Tumour necrosis factors (a, b) induced by HIV-64979;1 in peripheral blood mononuclear cells potentiate virus replication. AIDS, 1990; 4:21-64979;28.

  30. Tartaglia.L.A. and Goeddel, D.V. Two TNF receptors. Immunol. Today, 1992; 13:151-64979;153.

  31. Fazeli, F., Dezube, B.J., Allen-64979;Ryan, J., Pardee, A.B., and Ruprecht, R.M. PentoxifyIline (Trental) de creases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood, 1991; 77(8):1653-64979;1656.

  32. Wil-mer, J.L., Burleson, F.G., Kayama, F., Kanno, J., and Luster, M.I. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-64979;induced inflammation in mouse skin. J. Invest. Dermatol., 1994; 102(6):915-64979;922.

  33. Ray, K., Thompson, N., Kennard, N., Rollins, P., Grenfell, S., Witham, S., Smithers, N., and Solari, R. Investigation of guanine-64979;nucleotide-64979;binding protein involvement and regulation of cyclic AMP me tabolism in interleukin-64979;1 signal transcluction. Biochemical J., 1992; 282(Pt. 1):59-64979;67.

  34. Ahuja, S.K., Ozcelik, T., Milatovitch, A., Francke, U., and Murphy, P.M. Molecular evolution of the human interleukin-64979;8 receptor gene cluster. Nature Genetics, 1992; 2(1):31-64979;36.

  35. Bacon, K.B., Prernack, B.A., Gardner, P., and Schali, T.J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science, 1995; 269(5231):1727-64979;1730.

  36. Bischoff, S.C., Krieger, M., Brunner, T., Rot, A., von Tscharner, V., Baggiolini, M., and Dahinden, C.A. RANTES and related chemokines activate human basophil granulocytes through different G protein-64979;coupled receptors. Eur. J. Immunol., 1993; 23(3):761-64979;767.

  37. Fan, Y. and McCloskey, M.A. Dual pathways for GTP-64979;dependent regulation of chemoattractant-64979;acti vated K+ conductance in murine J774 monocytes. J. Biol. Chem., 1994; 269(50):31533-64979;31543.

  38. Kemeny, L., Ruzicka, T., Dobozy, A., and Michel, G. Role of interleukin-64979;8 receptor in skin. Int. Arch.Allergy & Immunol., 1994; 104(4):317-64979;322 .

  39. Mukaida, N. A newly discovered chemotactic factor for neutrophil: interleukin-64979;8. Rinsho Byori -64979; Jap.J. Clin. Pathol., 1992; 40(4):371-64979;379.

  40. Rot, A., Krieger, M., Brunner, T., Bischoff, S.C., Schali, T.J., and Dahinden, C.A. RANTES and macropliage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp, Med., 1992; 176(6):1489-64979;1495.

  41. Thelen, M., Uguccioni, M., and Bosiger, J. M 3-64979;kinase-64979;dependent and independent chemotaxis of human neutrophil leukocytes. Biochern. Biophys. Res, Commun., 1995; 217(3):1255-64979;1262.

  42. Wu, D., LaRosa, G.J., and Simon, M.¡. G protein-64979;coupled signal transcluction pathways for interleukin 8. Science, 1993; 261(5117):101-64979;103.

  43. Van Deventer, S.J.H., Hart, M., Van der Poli, T., Hack, C.E., and Aarden, L.A. Endotoxin and tumor necrosis factor-64979;a-64979;induced interleukin-64979;8 release in humans. J. Inf. Dis., 1993; 167:461-64979;464.

  44. Hakansson, B., Forsgren, A., Tegner, H., and Toremaim, N.G. Inhibitory effects of nasal drops compo nents on granulocyte chemotaxis. Pharmacol. & Toxicol., 1989; 64(4):321-64979;323.

  45. Bjerknes, R. and Steinsvag, S.K. Inhibition of human neutrophil actin polymerization, phagocytosis and oxidative burst by components of decongestive nosedrops. Pharmacol. & Toxicol., 1993; 73(1):415.

  46. Wenzel, H.R., FeIdmann, A., Engelbrecht, S., and Tschesche, H. Activation of the human leukocyte proteinases elastase and cathepsin G by various surfactants. Biol. Chem. Hoppe-64979;Seyler, 1990; 371(8):721 -64979;24.

  47. Kawa, J.E., Higginbotham, E.J., Chang, I.L., and Yue, B.Y. Effects of antiglaucoma medications on bovine trabecular meshwork cells in vitro. Exp. Eye Research, 1993; 57(5):557-64979;565.

  48. Fajardo, L.F., Kwan, H.H., Kowalski, J., Prionas, S.D., and Wilson, A.C. Dual role of tumor necrosis factor-64979;a in angiogenesis. Am. J. Pathol., 1992; 140:539-64979;544.

  49. Koch, A.E., Polverini, P.J., Kunkei, S.L., Harlow, L.A., DiPrieto, L.A., Einer, V.M., Einer, S.G. and R.M. Striter, R.M. Interleulkin-64979;8 as a macrophage-64979;derived mediator of angiogenesis. Science, 1992; 258:1798 1801.

  50. Leibovich, S.J., Polverini, P.J., Sheperd, H.M., Wiseman, D.M., Shively, V., and Nuseir, N. Macrophage induced angiogenesis is mediated by tumor necrosis factor-64979;alpha. Nature, 1987; 329:630-64979;632.

  51. Abrams, J. and Farhood, A.I. Infection-64979;associated vascular lesions in acquired immunodeficiency syndrome patients. Human Patho1,1989; 20(10):1025-64979;1026.

  52. Cáceres-64979;Ríos, H., Rodríguez-64979;Tafur, J., Bravo-64979;Puccio, F., Maguiña-64979;Vargas, C., Carrillo-64979;Ramos, D., and Patarca, R. Verruga peruana: An infectious endemic angiomatosis. Crit. Rev. Oncog., 1995; 6(1):47-64979;56. 

  53. Cockerell, C.J., Whiflow, M.A., Webster, G.F., and Friedman-64979;Kíen, A.E. Epithelloid angiomatosis: a distinct vascular disorder in patients with AIDS or AIDS-64979;related complex. Lancet, 1987; 2:654-64979;656.

  54. Cockerell, C.J. and LeBoit, P.E. Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous viscular disorder. J. Am. Acad. Dermatol., 1990; 22:501-64979;512.

  55. Cockerell, C., Tierno, P., Friedman-64979;Kien, A., and Kim, K.S. Clinical, histologic, microbiologic, and bio chemical characterization of causative agent of bacillary (epithelioid) angiomatosis: a rickettsial iliness with features of bartonellosis. J. Invest. Dermatol., 1991; 97:812-64979;817. 

  56. Dealler, S. Cat scratch disease, bartonellosis, and Kaposi sarcoma. Lancet, 1988; 2(8625):1422-64979;1423.

  57. Golciman, L. Bartonellosis and Kaposi sarcoma of AIDS. Lancet, 1989; 1(8462):852.

  58. LeBoit, P., Egoert, B.M., Stoler, M.H., Strauchen, J.A., Berger, T.G., Benedict Yen, T.S., Bonfiglio, T.A. English, C.K., and Wear, D.J. Epithelioid-64979;hemangioma-64979;like vascular proliferation in AIDS: manifesta tion of cat scratch disease bacillus infection? Lancet, 1988; 1:960-64979;963.

  59. Relman, D.A., Lepp, P.W., Sadier, K.N. and Schmidt, T.M. Phylogenetic relationships among the agent of bacillary angiomatosis, Bartonella bacilliformis, and other alplha-64979;proteobacteria. Mol. Microbiol, 1992; 6(13):650-64979;657.

  60. Stoler, M.H., Bonfiglio, T.A., Steigbigel, R.T., and Pereira, M. An atypical subcutaneous infection associated with AIDS. Am. J. Clin. Pathol., 1983; 80:714-64979;718.

  61. Wernert, N., Raes, M.B., Lasalle, P., Dehouck, M.P., Gosselin, B., Vandenbunder, B., and Stehelin, D. c-64979;ets 1 proto-64979;oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol., 1992; 140(1):119-64979;127.

  62. Pandey, A., Shao, H., Marks, R.M., Polverini, PA, and Dixit, V.M. WRole of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-64979;a-64979;induced angiogenesis. Science, 1995; 268:567-64979;569

  63. Camussi, G., Montrucchio, G., Lupia, E., De Martino, A., Perona, L., Arese, M., Vercellone, A., Toniolo, A. and Bussolino, F. Platelet-64979;activating factor directly stimulates in vítro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-64979;dependent mechanism. J. Immunol., 1995; 154:6492,6501.

  64. Montrucehio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G., and Camussi, G. Tumor necrosis factor-64979;a-64979;induced angiogenesis depends on in situ platelet-64979;activating factor biosynthesis. J. Exp. Med., 1994; 180:377~382.

  65. Brom, J. and Konig, W. Cytokine-64979;induced (interleukin-64979;3, -64979;6, and -64979;8 and tumour necrosis factor-64979;beta) activation and deactivation of human neutrophils. Immunology 1992; 75(2):281-64979;285.

  66. Akinsanya, A.A. and Whetton, A.D. IL-64979;3 stimulated haemopoietic stem cell proliferation: evidence for G protein independent mitogenic signaling events. J. Cell. Physiol., 1992; 152(2):245-64979;252.

  67. Nishigaki, N., Negishi, M., Sugimoto, Y., Namba, T., Narumiya, S., and Ichikawa, A. Characterization of the prostaglandin E receptor expressed on a cultured mast cell line, Bnu-64979;2cl3. Biochemical Pharmacol.1993; 46(5):863-64979;869.

  68. Vassiliadis, S. and Papamatheakis, J. The p2lras protein as an intermediate signaling molecule in the IL-64979;4-64979;induced HILA-64979;DR expression on normal and leulkemic human myeloid cells. Cellular Immunol. 1992; 142(2):426-64979;433.

  69. Clutterbuck, E.J. and Sanderson, CA Human eosinopihil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL-64979;5): production of functionally active eosinophils from normal human bone marrow. Blood, 1988; 71:646-64979;651.

  70. Coeffier, E., Joseph, D., and Vargaftig, B.B. Activation of guinea pig eosinophi1s by human recombinant IL-64979;5. Selective priming to platelet-64979;activating factor-64979;acether and interference of its antagonists. J.Immunol., 1992; 147:2595-64979;2602.

  71. Collins, P.D., Marleau, S., Griffiths-64979;Johnson, D.A., Jose, P.J., and Williams, T.J. Cooperation between interleulkin-64979;5 and the chemokine eotaxin to induce eosinopihil accumulation in vivo. J. Exp. Med.1995; 182:1169-64979;1174.

  72. Sanderson, C.J., Warren, D.G., and Strath, M. Identification of a lympholkine that stimulates eosinophil differentiation in vitro. Its relationship to interleulkin 3, and functional properties of eosinophi1s produced in cultures. J. Exp. Med., 1985; 162:60-64979;74.

  73. Sehmi, R., Warcilaw, A.J., Cromweil, 0., Kurihara, K., Waltmann, P., and Kay, A.B. Interleukin-64979;5 selec tively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood, 1992; 79:2952-64979;2959.

  74. 75. Tai, RC., Sun, L., and Spry, C.J.F. Effects of IL-64979;5, granulocytelmacrophage colony-64979;stimulating factor (GIVI-64979;CSF) and IL-64979;3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol., 1991; 85:312-64979;316.

  75. Warringa, R.A.J., Mengelers, H.J.J., Kuijper, RH.M., Raaijmakers, J.A.M., Bruijnzeel, RL.B., and Koenderman, L. In vivo priming of platelet-64979;activating factor-64979;induced eosinophil chemotaxis in aliergic asthmatic individuais. Blood, 1992; 79:1836-64979;1841.

  76. Yamaguchi, Y., Suda, T., Suda, J., Eguchi, M., Miura, Y., Harada, N., Tominaga, A., and Takatsu, K. Puri fied interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med., 1988; 167:43-64979;56.

  77. Lim, K.G., Wan, H.-64979;C., Bozza, P.T, Resnick, M.B., Wong, D.T.W., Cruikshank, W.W., Kornfeld, H., Center, D.M. and Weiler, P.F. Human eosinophils elaborate the lymphocyte chemoattractants IL-64979;16 (lympho cyte chemoattractant factor) and RANTES. J. Immunol., 1996; 156:2566-64979;2570.

  78. Mittrucker, H.W. and Fleischer, B. Functional localization of an exocytosis-64979;triggering G-64979;protein in human cytotoxic T lymphocytes. Immunology, 1992; 76(4):610-64979;615.

  79. Bonnema, J.D., Riviin, K.A., Ting, A.T., Schoon, R.A., Abraham, RT, and Leibson, RJ. Cytokine-64979;en hanced NK cell-64979;mediated cytotoxicity. Positive modulatory effects of IL-64979;2 and IL-64979;12 on stimulus dependent granule exocytosis. J. Immunol., 1994; 152(5):2098-64979;2104.

  80. Maghazachi, A.A. and Al-64979;Aoukaty, A. Gs is the major G protein involved in interleukin-64979;2-64979;activated natural killer (IANK) cell-64979;mediated cytotoxicity. Successfui introduction of anti-64979;G protein antibodies inside streptolysin 0-64979;permeabilized IANK cells. J. Biol. Chem., 1994; 269(9):6796-64979;6802.

  81. Willis, C.M., Stephens, C.J., and Wilkinson, J.D. Differential effects of structurally unrelated chemical irritants on the density and morphology of epidermal CD1+ cells. J. Investigative Dermatol., 1990; 95(6):711-64979;716.

  82. Beckman, E.M., Porcell, S.A., Morita, C.T., Behar, S.M., Furiong, S.T., and Brenner, M.B. Recognition of a lipid antigen by CD1-64979;restricted ab+ T cells. Nature, 1994; 372:691-64979;694.

  83. Bendelac, k, Olivier, L., Quimby, M.E., Yewdell, J.W., Bennink, R., and Brutkiewicz,'R.R. CD1 recognition by mouse NK11 T lymphocytes. Science, 1995; 268:863-64979;865.

  84.  Constant, P., Davodeau, F., Peyrat, M.-64979;A., Poquet, Y., Puzo, G., Bonneville, M., and Fournié, J.-64979;J. Stimu lation of human gd T cells by nonpeptidic mycobacterial ligands. Science, 1995; 264:267-64979;270.

  85. Sieling, P.A., Chatterjee, D., Porcelli, S.A., Prigozy, T.I., Mazzaccaro, R.J., Soriano, T., Bloom,
    B.R.,Brenner, M.B., Kronenberg, M., Brennan, P.J., and Modlin, R.L. CD1-64979;restricted T cell recognition of microbial lipoglycan antigens. Science, 1995; 269:227-64979;230.

  86. Lampe, M., Patarca, R., Iregui, M.V., and Cantor, H.l. PolycIonal B cell activation by Eta-64979;1 and autoimmunity. J. Immunol., 1991; 147:2902-64979;2906.

  87. Patarca, R., Freeman, G.J., Singh, R.P., Wei, F.-64979;Y., Durfee, T., Blattner, F., Regnier, D.C., Kozak, C.A. Mock, B.A., Morse, H.C.III., Jerrelis, T.R., and Cantor, H. Structural and functional studies of the Early T Lymphocyte Activation 1 (Eta-64979;1) gene. Definition of a novel T cell-64979;dependent response as sociated with genetic resistance to bacterial infection. J. Exp. Med., 1989; 170:145-64979;161.

  88. Patarca, R., Wei, F.-64979;Y., Singh, P., Morasso, IVII, and Cantor, H. Dysregulated expression of the T-64979;cell cytokine Eta-64979;1 in CD4-64979;8-64979; lymphocytes during the development of murine autoimmune disease. J. Exp. Med., 1990; 172:1177-64979;1183.

  89. Patarca, R., Saavedra, R.A., and Cantor, H. Molecular and cellular basis of genetic resistance to bac terial infection: The role of the Early T-64979;Iymphocyte activation-64979;llosteopontin gene. Crit. Rev. Immunol., 1993; 13(3/4):225-64979;246.

  90. Singh, R.P., Patarca, R., Schwartz, J., Singh, P., and Cantor, H. Definition of a specific interaction between eariymT-64979;Iymphocyte-64979;activation-64979;1 (eta-64979;1) protein and murine macrophages in vitro and in vivo. J. Exp. Med., 1990; 171:1931-64979;1942.

  91. Erny, R. and Siboni, C. Benzalkonium chloride tampons. Local tolerance and effects on cervix mu cus. Journal de Gynecologie, Obstetrique et Biológie de la Reproduction, 1983; 12(7):767-64979;774.

  92. Erny, R. and Siborni, C. The effect of benzalkonium chioride on ovulatory cervical mucus. Acta Europaea Fertilitatis, 1987; 18(2):109-64979;111.

  93. Frateschi, M., Zandonini, G.F., and Mazzoleni, G.C. Benzalkonium in local contraception and sexu ally-64979;transmitted diseases. Annali di Ostetricia, Ginecologia, Medicina Perinatale, 1990; 111(4):265-64979;269.

  94. Méndez, F., Castro, A., and Ortega, A. Use effectiveness of a spermicidal suppository containing benzalkonium chioride. Contraception, 1986; 34(4):353-64979;362.

  95. Zufferey, M.M. Real and false risks of local contraception: spermicides and the diaphragm. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 1985; 14(3):359-64979;363.

  96. Chantler, E., Fisher, H., Solanki, S., and Elstein, M. Quantification of the in vitro activity of some compounds with spermicidal activity. Contraception, 1992; 46(6):527-64979;536.

  97. Courtot, A.M., Nikas, G., Gravanis, A., and Psychoyos, A. Effects of cholic acid and Trotectaid' formu lations on human sperm motility and ultrastructure. Human Reproduction, 1994; 9(11):1999-2005.

  98. Meyer, U., Gerhard, l., and Runnebaum, B. Benzalkonium chloride for vaginal contraception – the vaginal sponge. Geburtshilfe und Frauenheilkunde, 1990; 50(7):542-547.

  99. Psychoyos, A., Creatsas, G., Hassan, E., Georgoulias, V., and Gravanís, A. Spermicidal and antiviral properties of a new vaginal sponge (Protectald) containing sodium cholate. Human Reproduction, 1993; 8(6):866-64979;869.

  100. Buttar, H.S. Embryotoxicity of benzalkonlum chloride in vaginally treated rats. J. Applied Toxicol. 1985; 5(6):398-401.

  101. Momma, J., Takada, K., Aida, Y., Takagi, A., Yoshimoto, H., Suzuki, Y., Nakaji, Y., Kurokawa, Y., and Tobe, M. Effects of benzalkonlum chloride on pregnant mice. Eisei Shikenjo Hokoku - Bulletin of National Institute if Hyqienic Sciences, 1987; 105:20-25.

Texto completo | Tabla de contenido

volumenes anteriores | revistas de Salud


© 1997-2003 UNMSM. Oficina General del Sistema de Bibliotecas y Biblioteca Central
Derechos reservados